|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cancer Genome Atlas Network: Comprehensive
molecular portraits of human breast tumours. Nature. 490:61–70.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ciriello G, Gatza ML, Beck AH, Wilkerson
MD, Rhie SK, Pastore A, Zhang H, McLellan M, Yau C, Kandoth C, et
al: Comprehensive molecular portraits of invasive lobular breast
cancer. Cell. 163:506–519. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Boon RA, Jaé N, Holdt L and Dimmeler S:
Long noncoding RNAs: From clinical genetics to therapeutic targets?
J Am Coll Cardiol. 67:1214–1226. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bhan A and Mandal SS: Long noncoding RNAs:
Emerging stars in gene regulation, epigenetics and human disease.
Chem Med Chem. 9:1932–1956. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ulitsky I and Bartel DP: lincRNAs:
Genomics, evolution, and mechanisms. Cell. 154:26–46. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Isin M and Dalay N: LncRNAs and neoplasia.
Clin Chim Acta. 444:280–288. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li X, Wu Z, Fu X and Han W: lncRNAs:
Insights into their function and mechanics in underlying disorders.
Mutat Res Rev Mutat Res. 762:1–21. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Maass PG, Luft FC and Bähring S: Long
non-coding RNA in health and disease. J Mol Med (Berl). 92:337–346.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang NS, Chi YY, Xue JY, Liu MY, Huang S,
Mo M, Zhou SL and Wu J: Long non-coding RNA metastasis associated
in lung adenocarcinoma transcript 1 (MALAT1) interacts with
estrogen receptor and predicted poor survival in breast cancer.
Oncotarget. 7:37957–37965. 2016.PubMed/NCBI
|
|
12
|
Si X, Zang R, Zhang E, Liu Y, Shi X, Zhang
E, Shao L, Li A, Yang N, Han X, et al: LncRNA H19 confers
chemoresistance in ERα-positive breast cancer through epigenetic
silencing of the pro-apoptotic gene BIK. Oncotarget. 7:81452–81462.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xu S, Sui S, Zhang J, Bai N, Shi Q, Zhang
G, Gao S, You Z, Zhan C, Liu F and Pang D: Downregulation of long
noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition
via the PI3K-AKT pathway in breast cancer. Int J Clin Exp Pathol.
8:4881–4891. 2015.PubMed/NCBI
|
|
14
|
Milevskiy MJ, Al-Ejeh F, Saunus JM,
Northwood KS, Bailey PJ, Betts JA, McCart Reed AE, Nephew KP, Stone
A, Gee JM, et al: Long-range regulators of the lncRNA HOTAIR
enhance its prognostic potential in breast cancer. Hum Mol Genet.
25:3269–3283. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Deng LL, Chi YY, Liu L, Huang NS, Wang L
and Wu J: LINC00978 predicts poor prognosis in breast cancer
patients. Sci Rep. 6:379362016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu SP, Zhang JF, Sui SY, Bai NX, Gao S,
Zhang GW, Shi QY, You ZL, Zhan C and Pang D: Downregulation of the
long noncoding RNA EGOT correlates with malignant status and poor
prognosis in breast cancer. Tumor Biol. 36:9807–9812. 2015.
View Article : Google Scholar
|
|
17
|
Mendell JT: Targeting a long noncoding RNA
in breast cancer. N Engl J Med. 374:2287–2289. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang Y, Qian J, Xiang Y, Chen Y and Qu J:
The prognostic value of long noncoding RNA HOTTIP on clinical
outcomes in breast cancer. Oncotarget. 8:6833–6844. 2017.PubMed/NCBI
|
|
19
|
Flockhart RJ, Webster DE, Qu K,
Mascarenhas N, Kovalski J, Kretz M and Khavari PA: BRAFV600E
remodels the melanocyte transcriptome and induces BANCR to regulate
melanoma cell migration. Genome Res. 22:1006–1014. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
McCarthy N: Epigenetics. Going places with
BANCR. Nat Rev Cancer. 12:4512012. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu Z, Yang T, Xu Z and Cao X:
Upregulation of the long non-coding RNA BANCR correlates with tumor
progression and poor prognosis in esophageal squamous cell
carcinoma. Biomed Pharmacother. 82:406–412. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Su S, Gao J, Wang T, Wang J, Li H and Wang
Z: Long non-coding RNA BANCR regulates growth and metastasis and is
associated with poor prognosis in retinoblastoma. Tumor Biol.
36:7205–7211. 2015. View Article : Google Scholar
|
|
23
|
Jiang W, Zhang D, Xu B, Wu Z, Liu S, Zhang
L, Tian Y, Han X and Tian D: Long non-coding RNA BANCR promotes
proliferation and migration of lung carcinoma via MAPK pathways.
Biomed Pharmacother. 69:90–95. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Peng ZQ, Lu RB, Xiao DM and Xiao ZM:
Increased expression of the lncRNA BANCR and its prognostic
significance in human osteosarcoma. Genet Mol Res. 15:2016.
View Article : Google Scholar
|
|
25
|
Fan YH, Ye MH, Wu L, Wu MJ, Lu SG and Zhu
XG: BRAF-activated lncRNA predicts gastrointestinal cancer patient
prognosis: A meta-analysis. Oncotarget. 8:6295–6303.
2017.PubMed/NCBI
|
|
26
|
Amin MB, Edge SB, Greene FL, Byrd DR,
Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR,
Sullivan DC, et al: American Joint Committee on Cancer (AJCC): AJCC
Cancer Staging Manual. 8th edition. Springer; New York, NY:
2017
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tsai JH and Yang J: Epithelial-mesenchymal
plasticity in carcinoma metastasis. Genes Dev. 27:2192–2206. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tsai MC, Spitale RC and Chang HY: Long
intergenic noncoding RNAs: New links in cancer progression. Cancer
Res. 71:3–7. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu H, Li J, Koirala P, Ding X, Chen B,
Wang Y, Wang Z, Wang C, Zhang X and Mo YY: Long non-coding RNAs as
prognostic markers in human breast cancer. Oncotarget.
7:20584–20596. 2016.PubMed/NCBI
|
|
31
|
Chen QN, Wei CC, Wang ZX and Sun M: Long
non-coding RNAs in anti-cancer drug resistance. Oncotarget.
8:1925–1936. 2017.PubMed/NCBI
|
|
32
|
Vennin C, Spruyt N, Robin YM, Chassat T,
Le Bourhis X and Adriaenssens E: The long non-coding RNA 91H
increases aggressive phenotype of breast cancer cells and
up-regulates H19/IGF2 expression through epigenetic modifications.
Cancer Lett. 385:198–206. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sas-Chen A, Aure MR, Leibovich L, Carvalho
S, Enuka Y, Körner C, Polycarpou-Schwarz M, Lavi S, Nevo N,
Kuznetsov Y, et al: LIMT is a novel metastasis inhibiting lncRNA
suppressed by EGF and downregulated in aggressive breast cancer.
EMBO Mol Med. 8:1052–1064. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gökmen-Polar Y, Vladislav IT, Neelamraju
Y, Janga SC and Badve S: Prognostic impact of HOTAIR expression is
restricted to ER-negative breast cancers. Sci Rep. 5:87652015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen JX, Chen M, Zheng YD, Wang SY and
Shen ZP: Up-regulation of BRAF activated non-coding RNA is
associated with radiation therapy for lung cancer. Biomed
Pharmacother. 71:79–83. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zheng H, Wang M, Jiang L, Chu H, Hu J,
Ning J, Li B, Wang D and Xu J: BRAF-activated long noncoding RNA
modulates papillary thyroid carcinoma cell proliferation through
regulating thyroid stimulating hormone receptor. Cancer Res Treat.
48:698–707. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang D, Wang D, Wang N, Long Z and Ren X:
Long non-coding RNA BANCR promotes endometrial cancer cell
proliferation and invasion by regulating MMP2 and MMP1 via ERK/MAPK
signaling pathway. Cell Physiol Biochem. 40:644–656. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li R, Zhang L, Jia L, Duan Y, Li Y, Bao L
and Sha N: Long non-coding RNA BANCR promotes proliferation in
malignant melanoma by regulating MAPK pathway activation. PLoS One.
9:e1008932014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang ZX, Liu ZQ, Jiang B, Lu XY, Ning XF,
Yuan CT and Wang AL: BRAF activated non-coding RNA (BANCR)
promoting gastric cancer cells proliferation via regulation of
NF-κB1. Biochem Biophys Res Commun. 465:225–231. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li L, Zhang L, Zhang Y and Zhou F:
Increased expression of LncRNA BANCR is associated with clinical
progression and poor prognosis in gastric cancer. Biomed
Pharmacother. 72:109–112. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Scaria V, Shi Y, Liu Y, Jie D, Yun T, Li
W, Yan L, Wang K and Feng J: Downregulated long noncoding RNA BANCR
promotes the proliferation of colorectal cancer cells via
downregualtion of p21 expression. PloS One. 10:e01226792015.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Guo Q, Zhao Y, Chen J, Hu J, Wang S, Zhang
D and Sun Y: BRAF-activated long non-coding RNA contributes to
colorectal cancer migration by inducing epithelial-mesenchymal
transition. Oncol Lett. 8:869–887. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sun M, Liu XH, Wang KM, Nie FQ, Kong R,
Yang JS, Xia R, Xu TP, Jin FY, Liu ZJ, et al: Downregulation of
BRAF activated non-coding RNA is associated with poor prognosis for
non-small cell lung cancer and promotes metastasis by affecting
epithelial-mesenchymal transition. Mol Cancer. 13:682014.
View Article : Google Scholar : PubMed/NCBI
|
